DE69429569T2 - Bis(hydroxymethyl)cyclopropylmethyl Pyrimidin Derivate, deren Herstellung und deren Verwendung als anti-virale Mittel - Google Patents

Bis(hydroxymethyl)cyclopropylmethyl Pyrimidin Derivate, deren Herstellung und deren Verwendung als anti-virale Mittel

Info

Publication number
DE69429569T2
DE69429569T2 DE69429569T DE69429569T DE69429569T2 DE 69429569 T2 DE69429569 T2 DE 69429569T2 DE 69429569 T DE69429569 T DE 69429569T DE 69429569 T DE69429569 T DE 69429569T DE 69429569 T2 DE69429569 T2 DE 69429569T2
Authority
DE
Germany
Prior art keywords
cyclopropylmethyl
hydroxymethyl
bis
preparation
pyrimidine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69429569T
Other languages
English (en)
Other versions
DE69429569D1 (de
Inventor
Tomoyuki Onishi
Chika Mukai
Takaaki Sekiyama
Takashi Tsuji
Satoshi Iwayama
Masahiko Okunishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Application granted granted Critical
Publication of DE69429569D1 publication Critical patent/DE69429569D1/de
Publication of DE69429569T2 publication Critical patent/DE69429569T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE69429569T 1993-10-21 1994-10-21 Bis(hydroxymethyl)cyclopropylmethyl Pyrimidin Derivate, deren Herstellung und deren Verwendung als anti-virale Mittel Expired - Lifetime DE69429569T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26349093 1993-10-21

Publications (2)

Publication Number Publication Date
DE69429569D1 DE69429569D1 (de) 2002-02-07
DE69429569T2 true DE69429569T2 (de) 2002-09-19

Family

ID=17390246

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69429569T Expired - Lifetime DE69429569T2 (de) 1993-10-21 1994-10-21 Bis(hydroxymethyl)cyclopropylmethyl Pyrimidin Derivate, deren Herstellung und deren Verwendung als anti-virale Mittel

Country Status (7)

Country Link
US (1) US5496824A (de)
EP (1) EP0649840B1 (de)
KR (1) KR950011530A (de)
CN (1) CN1106392A (de)
CA (1) CA2134050A1 (de)
DE (1) DE69429569T2 (de)
TW (1) TW271438B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2217026C (en) * 1996-02-22 2001-11-20 Samjin Pharmaceutical Co., Ltd. New antiviral substituted pyrimidinedione homocarbocyclic nucleoside derivatives and methods for the preparation thereof and compositions containing the same as active ingredients
ES2574785T3 (es) 2011-11-10 2016-06-22 Aratana Therapeutics Nv Procedimiento para preparar derivados de ciclopropano
BR112014017163A8 (pt) 2012-01-20 2017-07-04 Aratana Therapeutics Nv composição de colírio

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863927A (en) * 1987-05-11 1989-09-05 Merck & Co., Inc. 1-(2-hydroxymethyl)cycloalkylmethyl)-5-substituted uracils
CA2042931A1 (en) * 1990-05-24 1991-11-25 Robert Zahler Fluorinated bis (hydroxymethyl) cyclobutyl purines and pyrimidines
USH1142H (en) * 1990-11-05 1993-02-02 Optically active cyclobutyl pyrimidine
ES2139588T3 (es) * 1991-03-05 2000-02-16 Ajinomoto Kk Derivado de ciclopropano.

Also Published As

Publication number Publication date
KR950011530A (ko) 1995-05-15
CA2134050A1 (en) 1995-04-22
EP0649840B1 (de) 2002-01-02
US5496824A (en) 1996-03-05
DE69429569D1 (de) 2002-02-07
CN1106392A (zh) 1995-08-09
EP0649840A1 (de) 1995-04-26
TW271438B (de) 1996-03-01

Similar Documents

Publication Publication Date Title
ATE251161T1 (de) Triazolo(4,5-d)pyrimidin-derivate als antithrombotische mittel
DE69833223D1 (de) 4-aminothiazol derivate, deren herstellung und deren verwendung als inhibitoren cyclin-abhängiger kinasen
DE69427270D1 (de) Pyrimidin Derivate, Verfahren zu deren Herstellung und ihre Verwendung als herbizides Mittel
ATE380793T1 (de) N-phenyl-alkylsulfonamid-derivate, deren herstellung und deren verwendung als alpha1a/1l- adrenoceptor agonisten
ATE224910T1 (de) Derivate von dolestatin, deren herstellung und verwendung
ATE243682T1 (de) Heterozyklisch substituierte biphenylamid derivate, deren herstellung und deren verwendung als fungizide
ATE161253T1 (de) Derivate und analoge der 2-deoxy-2,3-didehydro-n- acetyl-neuraminsäure und ihre verwendung als antivirale agentien
DE122008000020I1 (de) Disubstituierte bicyclische heterocyclen, ihre herstellung und ihre verwendung als arzneimittel
ATE182880T1 (de) Alkylthio-oximäther-derivate und deren verwendung als fungizide
ATE245649T1 (de) 2,3-diaryl-pyrazolo(1,5-b)pyridazin derivate, deren herstellung und deren verwendung als cyclooxygenase 2 (cox-2) inhibitoren
DE69817611D1 (de) 2-aryl-8-oxodihydropurin-derivate, ihre herstellung, ihre verwendung als medikamentenkomponente und deren intermediate
DE59803292D1 (de) Triazolverbindungen und deren verwendung als dopamin-d 3-liganden
DE69929820D1 (de) Azyklische und zyklische guanidin- und acetamidin-derivate, deren herstellung und deren verwendung als pestizide, insbesondere als parasitizide
ATE261970T1 (de) Triazolo(4,5-d)pyrimidin-derivate
DE69410141D1 (de) 1-(substituiertes Phenyl)-Tetrazolinon Derivate, deren Herstellung und deren Verwendung als Herbizide
DE69804273D1 (de) 5h-Thiazolo[3,2-a]pyrimidinderivate
DE59711847D1 (de) Substituierte aza- und diazacycloheptan- und -cyclooctanverbindungen und deren verwendung
ATE259357T1 (de) Derivate von acyl-piperazinil-pyrimidinen, ihre herstellung und verwendung als medikament
DE19983612T1 (de) Derivate von Isosorbidmononitrat und deren Verwendung als Gefäßerweiterungsmittel mit verringerter Toleranz
BR9711724A (pt) Derivado de 3,4,5,6,7,8-hexaidro-pirido (4',3':4,5)tieno-(2,3-d) pirimidina 3-substitu¡da e uso do mesmo
DE69706690T2 (de) Acryloyl-substituierte distamycin-derivate, verfahren zu ihrer herstellung und ihre verwendung als antitumor- und antivirale mittel
ATE242197T1 (de) 3-amino-3-arylpropan-1-ol-derivate, deren herstellung und verwendung
ATE203011T1 (de) Distamycin derivate, verfahren zu ihrer herstellung sowie ihre verwendung als antitumor und antiviral wirkstoffe
DE69531801D1 (de) Benzopyrane und deren Verwendung als Heilmittel
DE59712148D1 (de) 1,3-dimethyl-5-fluor-pyrazol-4-carboxamide derivative, deren herstellung und deren verwendung als mikrobizide

Legal Events

Date Code Title Description
8364 No opposition during term of opposition